Reasons for increased substance use in psychosis (Q22252274)

Clinical Psychology Review

Europe PubMed Central

title

Reasons for increased substance use in psychosis (English)

0 references

1 reference

Lynsey Gregg

1

Lynsey

Gregg

1 reference

7 February 2023

Christine Barrowclough

series ordinal

2

object named as

Christine Barrowclough

author given names

Christine

author last names

Barrowclough

1 reference

7 February 2023

Gillian Haddock

3

Gillian

Haddock

1 reference

7 February 2023

language of work or name

English

0 references

publication date

May 2007

0 references

published in

0 references

volume

27

0 references

page(s)

494-510

0 references

issue

4

0 references

cites work

Self-control in psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Psychiatric and substance use comorbidity among treatment-seeking opioid abusers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Genetic and environmental influences on substance initiation, use, and problem use in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Schizophrenia, substance use disorders and medical co-morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Clinical characteristics of adolescents later hospitalized for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Prevalence of alcohol and drug abuse in schizophrenic inpatients

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance misuse at presentation to an early psychosis program

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Prevalence of substance misuse among individuals with severe mental illness in São Paulo

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Social exclusion in clients with comorbid mental health and substance misuse problems

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Expressed emotion and attributions in relatives of schizophrenia patients with and without substance misuse

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Increased tardive dyskinesia in alcohol-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use: a powerful predictor of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance abuse and related diagnoses in early psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Risk factors for experiencing psychosis during cocaine use: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Comorbid substance-use in schizophrenia: relation to positive and negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance abuse and the onset of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis use correlates with schizotypal personality traits in healthy students

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use disorders in schizophrenia: review, integration, and a proposed model

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Drug-use behavior and correlates in people with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Dual diagnosis: a review of etiological theories

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance misuse and psychiatric comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Addiction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Correlates of codisorders in homeless and never homeless indigent schizophrenic men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Persistent auditory hallucinations: coping mechanisms and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The impact of beliefs about mental health problems and coping on outcome in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Motivational interviewing among psychiatric in-patients with substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Medication adherence of individuals with a first episode of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Homelessness and dual diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use among the mentally ill: prevalence, reasons for use, and effects on illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Reasons for cannabis use in men with and without psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance-abusing schizophrenics: do they self-medicate?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Reasons for cannabis use in psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Patterns of current and lifetime substance use in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use in young adults with schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Interpersonal problem solving and information processing in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Coping with negative symptoms of schizophrenia: patient and family perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The schizophrenia envirome

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Parental Separation, Adolescent Psychopathology, and Problem Behaviors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Family history of alcoholism in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

A longitudinal study of substance use and community violence in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Relationships between symptoms of schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Lifetime victimization history, demographics, and clinical status in female psychiatric emergency room patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Drug use patterns and mental health of regular amphetamine users during a reported 'heroin drought'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Early adolescent cannabis exposure and positive and negative dimensions of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Tests of causal linkages between cannabis use and psychotic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis use predicts future psychotic symptoms, and vice versa

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Reasons for substance use in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis-induced psychosis-like experiences are associated with high schizotypy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Alcohol abuse, depression, and suicidal behavior in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Psychotic symptoms in an urban general medicine practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Early-onset substance abuse and community violence by outpatients with chronic mental illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Psychiatric disorder, drinking and alcoholism: what are the links?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Drug and alcohol problems among individuals with severe mental illness in south London

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Prevalence of substance misuse in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Psychosis and drug dependence: results from a national survey of prisoners

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Substance use and schizophrenia: effects on symptoms, social functioning and service use

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Comorbidity of substance misuse and mental illness in community mental health and substance misuse services.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Stimulant psychosis: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Prevalence and correlates of self-reported psychotic symptoms in the British population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Schizophrenia and suicide: systematic review of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Cannabis use and misuse prevalence among people with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Comorbid substance use and age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

Self reports of the interaction between substance abuse and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.CPR.2006.09.004

7 January 2021